Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 9 - Medicinal preparations characterised by special physical form
Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044)
09/2003
09/11/2003US20030170305 Sustained release over an extended period of time without an initial burst release of the agent(s) upon administration; outer layer of biodegradable polymer and inner portion of microcapsules formed from biodegradable polymer
09/11/2003US20030170304 Delivers an active ingredient in a pulsed or bimodal manner.
09/11/2003US20030170303 That has low water solubility such as celecoxib; and a release- extending polymer.
09/11/2003US20030170302 Permeable coating, preferably of water-permeable film-forming polymer (ethyl cellulose); a water-soluble polymer (polyvinyl pyrrolidone) and a plasticizer (stearic acid or dibutyl sebacate); specific dissolution profile
09/11/2003US20030170301 Effervescent composition including stevia
09/11/2003US20030170300 Combination chemotherapy
09/11/2003US20030170299 Therapeutic methods for acute myeloid leukemia
09/11/2003US20030170298 Treating oily bodies in cosmetically acceptable solvents with lecithins and/or phospholipids.
09/11/2003US20030170297 Lipid-based drug delivery systems containing phospholipase a2 degradable lipid derivatives for topical application to the skin
09/11/2003US20030170295 Hydrogel composition for transdermal drug delivery
09/11/2003US20030170294 Methods and devices for preventing transmission of sexually transmitted diseases
09/11/2003US20030170291 Biologically beneficial compound is formed on a cap assembly so that the compound passes into the mouth of a person drinking from the container through said cap assembly.
09/11/2003US20030170290 Reducing the problems of gastrointestinal irritation, dumping in the urine and bacterial degradation in oral administration
09/11/2003US20030170289 Injectable depot compositions and uses thereof
09/11/2003US20030170288 Drug delivery composition
09/11/2003US20030170287 Rapamycin or a rapamycin derivative having mTOR inhibiting properties
09/11/2003US20030170286 Codrug with at least two constituent moieties cleavably linked covalently to one another; dimensioned to position two radiation seeds a predetermined distance apart.
09/11/2003US20030170279 Emulsion vehicle for poorly soluble drugs
09/11/2003US20030170278 Includes a microcapsule, a semipermeable membrane capable of eliciting a fibrotic response from a higher order mammal, and a second matrix being of a thickness sufficient to prevent nucleation of fibrosis when implanted
09/11/2003US20030170273 Type 1 interferon inducers, such as double-stranded RNA, in combination with antigen delivery systems and/or immunostimulatory molecules for enhancing the immune response of a coadministered antigen
09/11/2003US20030170233 Treating Autoimmune Diseases with Humanized Anti-CD40L Antibody
09/11/2003US20030170217 Bifidobacterium in the treatment of inflammatory disease
09/11/2003US20030170216 SYN3 compositions and methods
09/11/2003US20030170215 Encapsulating a cell culture of propagating pancreatic cells; inserting the encapsulated cells into the mammal permitting the cells to mature to insulin secreting cells
09/11/2003US20030170209 Use of a vector comprising a nucleic acid coding for an anti-angiogenic factor for treating corneal neovascularization
09/11/2003US20030170207 For therapy of viral, tumorous and immune diseases
09/11/2003US20030170206 Interferon beta-like molecules
09/11/2003US20030170202 Hyperbranched polymeric micelles for encapsulation and delivery of hydrophobic molecules
09/11/2003US20030170201 Polymeric micelle containing cisplatin enclosed therein and use thereof
09/11/2003US20030170195 For dermal administration of drugs
09/11/2003US20030170194 Pharmaceutical and/or cosmetic composition containing an organosiloxane and a phospholipid
09/11/2003US20030170191 Hair growth stimulant compositions with sustained action
09/11/2003US20030170183 Promotes the release of the active particles from the carrier particles on actuation of the inhaler; efficiency
09/11/2003US20030170182 Topical spray for burn treatment and anti-infection
09/11/2003US20030170181 Method for preventing abuse of methylphenidate
09/11/2003US20030170177 Useful as vehicle for gene therapy, and in imaging
09/11/2003US20030168077 Coated micromesh dental devices overcoated with imbedded particulate
09/10/2003EP1342732A1 Pharmaceutical carrier comprising low-substituted cellulose ether, for external application
09/10/2003EP1342481A1 Convection-enhanced implantable drug delivery device
09/10/2003EP1342476A2 FGFR3 as a marker for mesenchymal skeletal progenitor cells and use of cytotoxic conjugates comprising an FGFR3 binding agent for the treatment of cartilagineous bony tumours
09/10/2003EP1342472A1 Analgesic and anti-inflammatory patches for external use containing 4-biphenylylylacetic acid
09/10/2003EP1342471A1 Nanocapsules based on polyol polyester, and cosmetic and dermatological compositions containing same
09/10/2003EP1342470A1 Fast release cefuroxime axetil compositions
09/10/2003EP1342469A2 Stable glass state powder formulations
09/10/2003EP1342462A1 O/w emulsion composition and method of preparing the same
09/10/2003EP1341821A1 Thermoplastic and water soluble cellulose ether esters
09/10/2003EP1341785A2 HYDROLYSIS OF R(R*,R*)]-2-(4-FLUOROPHENYL)-$g(b),$g(d) -DIHYDROXY-5-(1-METHYLETHYL)-3-PHENYL-4- (PHENYLAMINO)CARBONYL]-1H-PYRROLE-1-HEPTANOIC ACID ESTERS WITH CALCIUM HYDROXIDE
09/10/2003EP1341576A2 Implantable refillable and rate controlled drug delivery device
09/10/2003EP1341570A2 Patient activated administration of drug bolus from implantable drug delivery system having timer for lockout interval
09/10/2003EP1341569A2 Transcutaneous delivery means
09/10/2003EP1341565A2 Drug delivery compositions and coated medical devices
09/10/2003EP1341556A2 Drug delivery system
09/10/2003EP1341555A2 Pharmaceutical oxaliplatinum preparation for parenteral administration and method for obtaining same
09/10/2003EP1341546A2 Kyberdrug as autovaccines with immune-regulating effects
09/10/2003EP1341545A1 Bone putty and method
09/10/2003EP1341542A2 Organic compounds
09/10/2003EP1341538A2 Novel medicament compositions
09/10/2003EP1341536A2 Treatment of anti-depression drug-induced sexual dysfunction with apomorphine
09/10/2003EP1341530A1 Use of a dopamine agonist with a short half-life for treating illnesses which can be treated by dopaminergic means
09/10/2003EP1341529A2 Hydrolytically unstable compositions
09/10/2003EP1341528A1 Rapidly disintegrating tablet comprising an acid-labile active ingredient
09/10/2003EP1341527A1 Pharmaceutical preparation comprising an active dispersed on a matrix
09/10/2003EP1341526A2 Pharmaceutical compositions for the oral delivery of pharmacologically active agents
09/10/2003EP1341525A2 Novel process
09/10/2003EP1341524A2 Pharmaceutical preparation in the form of a paste comprising an acid-labile active ingredient
09/10/2003EP1341523A1 Pharmaceutical preparation in the form of a suspension comprising an acid-labile active ingredient
09/10/2003EP1341522A2 Microparticles with an improved release profile and method for the production thereof
09/10/2003EP1341521A2 Nanoparticulate compositions comprising a drug and copolymers of vinyl pyrrolidone and vinyl acetate as surface stabilizers
09/10/2003EP1341520A2 Antibiotic/benzoyl peroxide dispenser
09/10/2003EP1341519A2 Non-aspirating transitional viscoelastics for use in surgery
09/10/2003EP1341518A2 Cosmetic and/or pharmaceutical emulsions
09/10/2003EP1341515A1 Water-free skin care formulations comprising micronized urea and method of manufacturing the same
09/10/2003EP1341500A1 Antifungal nail composition and method of use
09/10/2003EP1341498A2 Medicated tattoos
09/10/2003EP1341497A2 Receptor antagonist-lipid conjugates and delivery vehicles containing same
09/10/2003EP1341476A2 Intrasvascular drug delivery device and use therefor
09/10/2003EP1341475A1 Intravascular blood conditioning device and use thereof
09/10/2003EP1341464A1 Treatment for epithelial diseases
09/10/2003EP1259513B1 A NOVEL CRYSTALLINE FORM OF N- 4- 2-(2-AMINO-4,7-DIHYDRO-4-OXO-3H-PYRROLO 2,3-d]PYRIMIDIN-5-YL)ETHYL]BENZOYL]-L-GLUTAMIC ACID AND PROCESS THEREFOR
09/10/2003EP1253937B1 Use of thrombin derived peptides for the treatment of cardiovascular disorders
09/10/2003EP1189600B1 Grf-containing lyophilized pharmaceutical compositions
09/10/2003EP1150657B1 SPRAY CONTAINING UBIQUINONE Qn
09/10/2003EP1135139B1 Micronized eplerenone compositions
09/10/2003EP1123089B1 Tablet for crunching with masked taste and instant release of active principle and method for making same
09/10/2003EP1109583B1 Method and device for delivery of therapeutic agents in conjuction with isotope seed placement
09/10/2003EP1053029B1 Sterile complex of therapeutic peptide bond to a polysaccharide
09/10/2003EP1035835B1 Long acting injectable formulations containing hydrogenated castor oil
09/10/2003EP1023052B1 Medicament excipient particles for tissue-specific application of a medicament
09/10/2003EP0991705B1 Open pore biodegradable matrices
09/10/2003EP0977553B1 Throat soothing compositions
09/10/2003EP0977541A4 Delivery systems for active ingredients including sunscreen actives and methods of making same
09/10/2003EP0973501B1 Aqueous suspension for nasal administration of loteprednol
09/10/2003EP0921806B1 Mannose-6-phosphate composition and its use in treating fibrotic disorders
09/10/2003EP0914091B1 Ethene containing solutions and use thereof in methods of therapy or prophylaxis
09/10/2003EP0901384B1 Polysaccharide sponges for cell culture and transplantation
09/10/2003EP0783299B1 Compounds and compositions for delivering active agents
09/10/2003EP0772463B1 Alginate fibre, process for the preparation thereof and use
09/10/2003EP0731703B1 Liposomal formulations containing vidarabine or its derivatives
09/10/2003EP0689843B1 Composition containing soluble thrombomodulins
09/10/2003CN1441704A Medium milling
1 ... 2095 2096 2097 2098 2099 2100 2101 2102 2103 2104 2105 2106 2107 2108 2109 2110 2111 2112 2113 2114 2115 ... 2991